Manatuck Hill Partners’s BioLife Solutions BLFS Stock Holding History

Manatuck Hill Partners’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-64,200	Closed	-$1.12M	–	94
2018 Q3	$1.12M	Hold	64,200	–	–	0.42%	47
2018 Q2	$733K	Buy	64,200 +14,200	+28%	+$129K	0.29%	58
2018 Q1	$257K	Hold	50,000	–	–	0.14%	70
2017 Q4	$300K	Hold	50,000	–	–	0.16%	68
2017 Q3	$286K	Buy	+50,000	New	+$207K	0.14%	68

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

SCM

Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

CCM

Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Manatuck Hill Partners's BLFS Position: Q4 2018 in Review

Manatuck Hill Partners sold out of BioLife Solutions (BLFS) in Q4 2018, closing a stake of 64,200 shares — an estimated $1.12M sold.

Manatuck Hill Partners first reported a position in BLFS in Q3 2017 and held it in 5 quarters. The position peaked at $1.12M in Q3 2018. 54 funds tracked by Wall St. Rank hold BLFS as of Q4 2018.

Manatuck Hill Partners reported no remaining BioLife Solutions position as of Q4 2018 after selling out during the quarter.
Manatuck Hill Partners sold 64,200 BioLife Solutions shares in Q4 2018, an estimated $1.12M.
Manatuck Hill Partners first reported a position in BioLife Solutions in Q3 2017 and held it in 5 quarters.
Manatuck Hill Partners's BioLife Solutions position peaked at $1.12M in Q3 2018.
54 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2018.

Based on Manatuck Hill Partners's 13F filing for Q4 2018, filed 14 Feb 2019.